Year: 2003 Source: Archives of Women's Health, v.6, (2003), p.287-282 SIEC No: 20040513

Women were recruited from 6 primary care obstetric-gynecological practices for participation in an open trial assessing the effectiveness of a serotonin reuptake inhibitor as a treatment for subsyndromal (3-4 symptoms) & syndromal (> 4 symptoms) premenstrual dysphoric disorder (PMDD). 24% of women with possible PMDD endorsed suicidal thoughts at any level (several days, more than half the days, or every day); 20% endorsed these thoughts for several days. These results & their implications are discussed. (35 refs)